54 Gene

Founded 

2018

 in 

San Francisco, CA
54 Gene’s mission is to advance the state of healthcare through large scale discovery and translational research, advanced molecular diagnostics, and clinical programs for the benefit of everyone. 54 Gene offers and improves the application of genomics and AI in the diagnosis and treatment of people. Their first product, 54Gene, is building the world’s first and largest pan-African biobank targeting multiple disease states, including cancer, cardiovascular disease, and neuro-degenerative disease. 54Gene partners with pharmaceutical companies to identify new drug targets and develop diagnostics and treatments for diseases.

Abisi Ene-Obong (Co-Founder & CEO) (abasi@54gene.com)

Ogochukwu Francis Osifo (Co-founder & CTO)

Stay Tuned

Subscribe to our newsletter and get updates on our portfolio companies.